Format

Send to

Choose Destination
Mol Neuropsychiatry. 2016 Jul;2(2):88-96. Epub 2016 Jun 22.

Leukocyte telomere length predicts SSRI response in major depressive disorder: A preliminary report.

Author information

1
Department of Psychiatry, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, USA.
2
Department of Psychiatry, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, USA; Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.
3
Department of OB/GYN and Reproductive Science, UCSF School of Medicine, San Francisco, CA, USA.
4
Department of Psychiatry, University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, USA; Department of Clinical Sciences, Section for Psychiatry, Lund University, Lund, Sweden.
5
Department of Biochemistry and Biophysics, UCSF School of Medicine, San Francisco, CA, USA.

Abstract

Short leukocyte telomere length (LTL) may be associated with several psychiatric disorders, including major depressive disorder (MDD). Short LTL has previously been associated with poor response to psychiatric medications in bipolar disorder and schizophrenia, but no studies have prospectively assessed the relationship of LTL to SSRI response in MDD. We assessed pre-treatment LTL, depression severity (using the Hamilton Depression Rating Scale [HDRS]), and self-reported positive and negative affect in 27 healthy, unmedicated adults with MDD. Subjects then underwent open-label treatment with a selective serotonin reuptake inhibitor (SSRI) antidepressant for eight weeks, after which clinical ratings were repeated. Analyses were corrected for age, sex and BMI. "Non-responders" to treatment (HDRS improvement <50%) had significantly shorter pre-treatment LTL, compared to "Responders" (p=0.037). Further, shorter pre-treatment LTL was associated with less improvement in negative affect (p<0.010) but not with changes in positive affect (p=0.356). This preliminary study is the first to assess the relationship between LTL and SSRI response in MDD and among the first to prospectively assess its relationship to treatment outcome in any psychiatric illness. Our data suggest that short LTL may serve as a vulnerability index of poorer response to SSRI treatment, but this needs examination in larger samples.

KEYWORDS:

Affect; Affective disorder; Antidepressants; Biomarker; Depression; Major depression; Mood disorders; Selective serotonin reuptake inhibitors; Telomer; Treatment response

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland Icon for PubMed Central
Loading ...
Support Center